BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldaracena N, Wolf MM, Quiñonez E, Anders M, Mastai R, Mccormack L. Is it safe to use a liver graft from a chagas disease-seropositive donor in a human immunodeficiency virus-positive recipient? A case report addressing a novel challenge in liver transplantation. Liver Transpl 2012;18:979-83. [DOI: 10.1002/lt.23452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Liang J, Lv J, Liu Z. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process. Exp Mol Pathol 2015;98:540-5. [PMID: 25805103 DOI: 10.1016/j.yexmp.2015.03.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Contreras AG, McCormack L, Andraus W, de Souza M Fernandes E; Latin America Liver Transplantation Group. Current status of liver transplantation in Latin America. Int J Surg 2020;82S:14-21. [PMID: 32247089 DOI: 10.1016/j.ijsu.2020.03.039] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Shikanai Yasuda MA. Emerging and reemerging forms of Trypanosoma cruzi transmission. Mem Inst Oswaldo Cruz 2022;117:e210033. [PMID: 35584508 DOI: 10.1590/0074-02760210033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]